ClinicalTrials.gg
TerminatedNCT00204997Updated Nov 15, 2019

Preservation of Ovarian Function Via LOT in Squamous Cell Carcinoma of the Cervix

An interventional study of Laparoscopic ovarian transposition in Cervical Cancer, sponsored by University of Wisconsin, Madison. Terminated at 1 site in United States. Open to female participants aged 18 Years to 40 Years. Per ClinicalTrials.gov, last updated 2019-11-15.

Sponsored by University of Wisconsin, Madison · Not applicable, Interventional, and Treatment

Why this study was terminated
slow accrual
Phase
Not applicable
Study type
Interventional
Enrollment
10
Allocation
Non-randomized
Ages
18 Years to 40 Years
Sex
Female
01

Study summary

The purpose of this study is to evaluate the feasibility, safety and efficacy of laparoscopic ovarian transposition in women less than 40 years of age with locally advanced cervical squamous cell carcinoma

02

Conditions studied

  • Cervical Cancer

Keywords

  • Cervical Cancer
  • Squamous Cell
  • Laparoscopy
  • Ovarian Function
03

In context

Uterine Cervical Neoplasms

1,927 studies on the registry are indexed under Uterine Cervical Neoplasms; 576 are open to participants now.

This study's planned enrollment of 10 is below the median of 100 across 1,411 interventional studies indexed under Uterine Cervical Neoplasms.

Browse Uterine Cervical Neoplasms studies →

Lead sponsor

University of Wisconsin, Madison is the lead sponsor of 1,182 studies on the registry; 180 are open to participants now.

Of its 156 completed or terminated interventional studies of FDA-regulated products, 118 (76%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 40 Years
Sexes eligible
Female
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Newly diagnosed Stages iB-iiiB squamous cell carcinoma of the cervix

Exclusion criteria

Exclusion Criteria:

  • Evidence of ovarian involvement on MRI
  • Evidence of uterine involvement on MRI
  • Evidence of distant mets on MRI
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Non-randomized
Intervention model
Single group
Masking
None (open label)
Enrollment
10 participants (estimated)

Study arms

  • Experimental
    1

    Laparoscopic Ovarian Transposition

    Procedure: Laparoscopic ovarian transposition

Interventions

  • ProcedureLaparoscopic ovarian transposition

    Laparoscopic ovarian transposition

06

What researchers measure

Primary outcomes

  1. Menopause

    Time frame: 6 months

07

Study locations

1 site
  • University of Wisconsin
    Madison, Wisconsin 53792, United States
08

References and documents

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 15, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT00204997
Responsible party
Sponsor
First posted
Sep 20, 2005
Start date
Sep 2002
Primary completion
Sep 2005
Completion
Feb 2008
Last update
Nov 15, 2019

Study contacts

David M Kushner, MD
principal investigator · University of Wisconsin, Madison

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is terminated, as verified in Jun 2008. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion